methacycline

Suppliers

Names

[ CAS No. ]:
914-00-1

[ Name ]:
methacycline

[Synonym ]:
Germicilclin
Adriamicina
gs-2876
6-methylene-oxytetracyclin
METHACYCLINE
Globociclina
6-methyleneoxytetracycline
rondomycin
metacycline
bialatan
methacyclineamphoteric
Cyclobiotic
12aalpha))-ph

Chemical & Physical Properties

[ Density]:
1.66g/cm3

[ Boiling Point ]:
695.1ºC at 760mmHg

[ Melting Point ]:
>150°C (dec.) (lit.)

[ Molecular Formula ]:
C22H22N2O8

[ Molecular Weight ]:
442.41900

[ Flash Point ]:
374.2ºC

[ Exact Mass ]:
442.13800

[ PSA ]:
181.62000

[ LogP ]:
0.26240

[ Index of Refraction ]:
1.753

[ Storage condition ]:
2-8°C

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
QI9275000
CHEMICAL NAME :
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro- 3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-
CAS REGISTRY NUMBER :
914-00-1
LAST UPDATED :
199506
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C22-H22-N2-O8
MOLECULAR WEIGHT :
442.46
WISWESSER LINE NOTATION :
L E6 C666 BV FV MY CU GU LHTT&&J DQ EQ GVZ HQ IN1&1 KQ MU1 RQ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
660 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value

MUTATION DATA

TYPE OF TEST :
DNA inhibition
TEST SYSTEM :
Human Lymphocyte
DOSE/DURATION :
3750 ug/L
REFERENCE :
BCPHBM British Journal of Clinical Pharmacology. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.1- 1974- Volume(issue)/page/year: 16,127,1983 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X1538 No. of Facilities: 11 (estimated) No. of Industries: 1 No. of Occupations: 5 No. of Employees: 1150 (estimated) No. of Female Employees: 591 (estimated)

Related Compounds

  • Methacycline HCl
  • methacycline hydrochloride
  • tert-butyl N-[4-hydroxy-2-(6-oxo-1,6-dihydropyridazin-1-yl)cyclohexyl]carbamate
  • 3-[Cyclobutyl(methyl)amino]-4-(2-methylbutan-2-yl)cyclohexan-1-ol
  • 5-[(2R)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanamido]-2,4-difluorobenzoic acid
  • 3-[(Cyclopropylmethyl)(ethyl)amino]-4-(2-methylbutan-2-yl)cyclohexan-1-ol
  • 4-(2-Methylbutan-2-yl)-3-(4-methylpiperidin-1-yl)cyclohexan-1-ol
  • 3-(Azepan-1-yl)-4-(2-methylbutan-2-yl)cyclohexan-1-ol
  • 4,4-Dimethyl-3-[methyl(1-methylpyrrolidin-3-yl)amino]cyclohexan-1-ol
  • 3-[3-(Methoxymethyl)pyrrolidin-1-yl]-4,4-dimethylcyclohexan-1-ol
  • 3-[(2,3-Dimethylbutyl)(methyl)amino]-4,4-dimethylcyclohexan-1-ol
  • 3-[(1-Cyclopropylpropyl)(methyl)amino]-4,4-dimethylcyclohexan-1-ol
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.